Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
diabetes
2
×
national blog main
novartis
2
×
seattle blog main
seattle top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biotech
biotech ipos
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cerner
chronic conditions
cidara therapeutics
cigna
clinical trials
concert pharmaceuticals
cvs health
deals
detroit blog main
What
patients
2
×
advantages
aims
bar
bio
brings
changes
diet
digital
doctors
drug
drugs
exercise
expect
gamble
gets
health
market
medco’s
medical
mover
new
payers
physicians
plan
prescribe
prescribing
pricing
procedures
regimen
roundup
services
sets
software
sorts
surescripts
things
type
ubiome
undone
Language
unset
Current search:
novartis
×
patients
×
diabetes
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services
